← All authors Ruth Etzioni Fred Hutch Cancer Center (per OpenAlex) · ORCID · OpenAlex
65 papers in scope · 64 published · 1 on the econ.EM arXiv · 3,704 citations · h-index 26 (over the papers listed here)
Papers (1 of 65)
Abstract B053: A multi-method, collaborative approach in evaluating the experiences and identifying equity-related barriers for Black individuals in follow up care for radical prostatectomy and secondary treatment
published 2025 · Cancer Epidemiology Biomarkers & Prevention
with Dante Morehead, Jenney R. Lee, Ben Young, Victor Tolbert, John Masembe, Sarah K. Holt, Yohali Burrola-Mendez, Sung Min Kim, Liz Sage, Erika M. Wolff, J. D. Morales Mendoza, John L. Gore, …
Letter to the editor regarding “Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies”
published 2025 · Pancreatology · 1 citations
with Stuart G. Baker
Breast density and risk of breast cancer: masking and detection bias
published 2024 · American Journal of Epidemiology · 8 citations
with Jane Lange, Charlotte C. Gard, Ellen S. O’Meara, Diana L. Miglioretti
Considerations for using potential surrogate endpoints in cancer screening trials
published 2024 · The Lancet Oncology · 24 citations
with Alexis B Webb, Christine D. Berg, Philip E. Castle, David L. Crosby, Larry G. Kessler, Usha Menon, Mahesh Parmar, R. Steele, Peter Sasieni
Screening for Cancer Precursor Lesions: Assessing the Impact on Cancer Incidence in Randomized Trials
published 2023 · Epidemiology · 2 citations
with Noel S. Weiss
Test sensitivity in a prospective cancer screening program: A critique of a common proxy measure
published 2023 · Statistical Methods in Medical Research · 9 citations
with Jane Lange, Yibai Zhao, Kemal Çağlar Göğebakan, Antonio Olivas-Martínez, Marc D. Ryser, Charlotte C. Gard
working paper 2023 · arXiv
Abstract B100: The role of place in racial disparities in prostate cancer treatment
published 2023 · Cancer Epidemiology Biomarkers & Prevention · 1 citations
with Noah Hammarlund, Jenney Lee, Erika M. Wolff, Sarah K. Holt, John L. Gore, Yaw A. Nyame
PCN175 Pan-Cancer Early Detection Tests: Considering Potential Benefits and Harms
published 2021 · Value in Health
with Boshen Jiao, Roman Gulati
PCN166 Comparative Effectiveness and Cost-Effectiveness of Reflex Testing Men with Intermediate PSA Levels: A Systematic Model-Based Analysis
published 2021 · Value in Health
with Bin Jiao, R. Gulati, Nathaniel Hendrix, James Gore, Soroush Rais-Bahrami, Jeffrey J. Tosoian, Michael W. Kattan, Todd M. Morgan
Clarifying the Trade-Offs of Risk-Stratified Screening for Prostate Cancer: A Cost-Effectiveness Study
published 2021 · American Journal of Epidemiology · 16 citations
with Nathaniel Hendrix, Roman Gulati, Boshen Jiao, A. Karim Kader, Stephen Ryan
Reply by Authors
published 2019 · The Journal of Urology
with Roman Gulati, Sarah P. Psutka
A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data
published 2019 · PLoS ONE · 17 citations · first circulated 2018
with Andreas Karlsson, Alexandra Jauhiainen, Roman Gulati, Martin Eklund, Henrik Grönberg, Mark Clements
Estimating and comparing cancer progression risks under varying surveillance protocols
published 2018 · The Annals of Applied Statistics · 13 citations
with Jane Lange, Janet E. Cowan, Lawrence Klotz, Roman Gulati, Amy Leonardson, Daniel W. Lin, Lisa F. Newcomb, Bruce J. Trock, H. Ballentine Carter, Peter R. Carroll, Matthew R. Cooperberg
Estimating the frequency of indolent breast cancer in screening trials
published 2018 · Statistical Methods in Medical Research · 14 citations
with Yu Shen, Wenli Dong, Roman Gulati, Marc D. Ryser
A Framework for Treatment Decision Making at Prostate Cancer Recurrence
published 2017 · Medical Decision Making · 7 citations
with Jane Lange, Bruce J. Trock, Roman Gulati
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States
published 2017 · Cancer Epidemiology Biomarkers & Prevention · 555 citations
with Angela B. Mariotto, Marc Hurlbert, Lynne Penberthy, Musa Mayer
Beyond classical risk adjustment: Socioeconomic status and hospital performance in urologic oncology.
published 2017 · Journal of Clinical Oncology
with Anobel Y. Odisho, John L. Gore
Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies
published 2016 · American Journal of Epidemiology · 34 citations
with Roman Gulati, Eric J. Feuer
Comparative Effectiveness of Biomarkers to Target Cancer Treatment
published 2015 · Medical Decision Making · 4 citations
with Jeanette K. Birnbaum, Foluso O. Ademuyiwa, Josh J. Carlson, Leslie Mallinger, Mark W. Mason
Measures of survival benefit in cancer drug development and their limitations
published 2015 · Urologic Oncology Seminars and Original Investigations · 7 citations
with Roman Gulati, Daniel W. Lin
Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors
published 2014 · Journal of Clinical Oncology · 56 citations
with Scott D. Ramsey, N. Lynn Henry, Julie R. Gralow, Dana K. Mirick, William E. Barlow, David Mummy, Rahber Thariani, David L. Veenstra
Modeling grade progression in an active surveillance study
published 2013 · Statistics in Medicine · 55 citations
with Lurdes Y. T. Inoue, Bruce J. Trock, Alan W. Partin, Herbert B. Carter
Should Modest Elevations in Prostate-Specific Antigen, International Prostate Symptom Score, or Their Rates of Increase Over Time be Used as Surrogate Measures of Incident Benign Prostatic Hyperplasia?
published 2013 · American Journal of Epidemiology · 3 citations
with J. M. Schenk, Rachel Hunter-Merrill, Yingye Zheng, R. Gulati, Cathy Tangen, Ian M. Thompson, Alan R. Kristal
Building Better Models
published 2012 · Medical Decision Making · 20 citations
with Jeanne S. Mandelblatt, Clyde B. Schechter, David T. Levy, Ann G. Zauber, Yao-Jen Chang
Deriving benefit of early detection from biomarker-based prognostic models
published 2012 · Biostatistics · 4 citations
with Lurdes Y. T. Inoue, Roman Gulati, Cheburkayeva M.Yu., Michael W. Kattan
Calibrating disease progression models using population data: a critical precursor to policy development in cancer control
published 2010 · Biostatistics · 59 citations
with Roman Gulati, Lurdes Y. T. Inoue, Jerald Katcher, William D. Hazelton
Methods for Assessing Improvement in Specificity When a Biomarker is Combined With a Standard Screening Test
published 2009 · Statistics in Biopharmaceutical Research · 25 citations
Differential Expression and Network Inferences through Functional Data Modeling
published 2008 · Biometrics · 13 citations
with Donatello Telesca, Lurdes Y. T. Inoue, Mauricio Neira, Martin Gleave, Colleen C. Nelson
Modeling Disease Progression With Longitudinal Markers
published 2008 · Journal of the American Statistical Association · 22 citations
with Lurdes Y. T. Inoue, Christopher Morrell, Peter Müller
Impact of PSA Screening on the Incidence of Advanced Stage Prostate Cancer in the United States: A Surveillance Modeling Approach
published 2008 · Medical Decision Making · 103 citations
with Roman Gulati, Seth Falcon, David F. Penson
Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends
published 2007 · Biometrics · 126 citations
with Donatello Telesca, Roman Gulati
Modeling the Effect of a Preventive Intervention on the Natural History of Cancer: Application to the Prostate Cancer Prevention Trial
published 2006 · The International Journal of Biostatistics · 2 citations
with Paul F. Pinsky, Nadia Howlader, Phyllis J. Goodman, Ian M. Thompson
Cluster-based network model for time-course gene expression data
published 2006 · Biostatistics
with Lurdes Y. T. Inoue, Mauricio Neira, Colleen C. Nelson, Martin Gleave
Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer
published 2005 · The American Journal of Medicine · 72 citations
with Steven B. Zeliadt, David F. Penson, Ian M. Thompson, Scott D. Ramsey
The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing
published 2004 · Statistical Methods in Medical Research · 42 citations
with Eric J. Feuer, Kathleen A. Cronin, Angela B. Mariotto
Case-Control Studies of the Efficacy of Cancer Screening
published 2004 · Epidemiology · 19 citations
with Noel S. Weiss, Preet K. Dhillon
Can Administrative Data Identify Incident Cases of Colorectal Cancer? A Comparison of Two Health Plans
published 2004 · Health Services and Outcomes Research Methodology · 8 citations
with Scott D. Ramsey, Margaret T. Mandelson, Robert G. Harrison, Robert Smith, Stephen H. Taplin
Combining biomarkers to detect disease with application to prostate cancer
published 2003 · Biostatistics · 96 citations
Estimating the Influence of Rescreening Interval on the Benefits Associated with Cancer Screening: Approaches and Limitations
published 2002 · Epidemiology · 21 citations
with Noel S. Weiss
Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data
published 2002 · Medical Care · 615 citations
with Martin L. Brown, Gerald F. Riley, Nicki Schussler
Measuring Costs
published 2002 · Medical Care · 32 citations
with Gerald F. Riley, Scott D. Ramsey, Martin L. Brown
Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer
published 2002 · The American Journal of Gastroenterology · 45 citations
with Scott D. Ramsey, Kristin H. Berry
The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study
published 2001 · Health Economics · 53 citations
with Scott D. Ramsey, Kristin Berry, Martin L. Brown
SIMULATION MODELING OF OUTCOMES AND COST EFFECTIVENESS
published 2000 · Hematology/Oncology Clinics of North America · 39 citations
with Scott D. Ramsey, Martin McIntosh, Nicole Urban
Obtaining Long-Term Disease Specific Costs of Care
published 1999 · Medical Care · 180 citations
with Martin L. Brown, Gerald F. Riley, Arnold L. Potosky
Incorporating the Time Dimension in Receiver Operating Characteristic Curves: A Case Study of Prostate Cancer
published 1999 · Medical Decision Making · 110 citations
with Margaret S. Pepe, Gary Longton, Chengcheng Hu, Gary Goodman
On the use of survival analysis techniques to estimate medical care costs
published 1999 · Journal of Health Economics · 114 citations
with Eric J. Feuer, Sean D. Sullivan, D. Y. Lin, Chengcheng Hu, Scott D. Ramsey
Assessing uncertainty in microsimulation modelling with application to cancer screening interventions
published 1998 · Statistics in Medicine · 26 citations
with Kathleen A. Cronin, Julie Legler
Asymptomatic Incidence and Duration of Prostate Cancer
published 1998 · American Journal of Epidemiology · 128 citations
with Raymond Cha, Eric J. Feuer, Ori Davidov
Analysis of Case-Control Studies of Screening: Impact of Misspecifying the Duration of Detectable Preclinical Pathologic Changes
published 1998 · American Journal of Epidemiology · 26 citations
with N. S. Welss
Optimizing Sampling Strategies for Estimating Quality-adjusted Life Years
published 1997 · Medical Decision Making · 12 citations
with Scott D. Ramsey, Andrea B. Troxel, Nicole Urban
Estimating Medical Costs from Incomplete Follow-Up Data
published 1997 · Biometrics · 457 citations
with D. Y. Lin, Eric J. Feuer, Yohanan Wax
ESTIMATING ASYMPTOMATIC DURATION IN CANCER: THE AIDS CONNECTION
published 1997 · Statistics in Medicine · 17 citations
with Yu Shen
Prostate cancer and computer models: Background, limitations, and potential
published 1996 · Urologic Oncology Seminars and Original Investigations · 4 citations
with Ian M. Thompson
Estimating the costs attributable to a disease with application to ovarian cancer
published 1996 · Journal of Clinical Epidemiology · 93 citations
with Nicole Urban, Mary S. Baker
the catch-up time method for analyzing cancer screening trials (Biometrics (March 1995) 51 (31-43)
published 1995 · Biometrics
with Steven G. Self
no link
Bayesian Statistical Methods in Public Health and Medicine
published 1995 · Annual Review of Public Health · 89 citations
with Joseph B. Kadane
Design and analysis of cancer screening trials
published 1995 · Statistical Methods in Medical Research · 46 citations
with Robert Connor, Philip C. Prorok, Steven G. Self
On the Catch-Up Time Method for Analyzing Cancer Screening Trials
published 1995 · Biometrics · 26 citations
with Steven G. Self
A Likelihood Ratio Test for Cancer Screening Trials
published 1995 · Biometrics · 16 citations
with Steven G. Self
Monitoring of a pilot toxicity study with two adverse outcomes
published 1994 · Statistics in Medicine · 19 citations
with Margaret S. Pepe
Statistical models for the analysis of ordered categorical data in public health and medical research
published 1994 · Statistical Methods in Medical Research · 10 citations
with Stephen E. Fienberg, Zvi Gilula, Shelby J. Haberman
Statistical Methods for Analyzing Speedup Learning Experiments
published 1994 · Machine Learning · 28 citations
with Oren Etzioni, Open Etzioni, Steven Minton
Optimal Experimental Design for Another's Analysis
published 1993 · Journal of the American Statistical Association · 61 citations
with Joseph B. Kadane
Assembled from arXiv and OpenAlex. Duplicate records for the same paper are merged, and the published version is shown where we could identify one. Corrections welcome.
Built from arXiv and OpenAlex. Supported by UKRI grant APP47921 (Martin Weidner, UCL · Francis J. DiTraglia, Oxford).